C

Crinetics Pharmaceuticals

202 employees

Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
RareDisease
Pharmaceutical
Drug Discovery
Endocrinology

Date founded

2008

Funding rounds raised

Total raised

$75M

from 14 investors over 14 rounds

C

Crinetics Pharmaceuticals raised $15M on July 29, 2021

Investors: Frazier Healthcare Partners

C

Crinetics Pharmaceuticals raised $75M on April 12, 2021

Investors: Driehaus Capital Management LLC

C

Crinetics Pharmaceuticals raised $3.2M on June 21, 2018

Investors: National Institutes of Health

C

Crinetics Pharmaceuticals raised $64M on March 13, 2018

Investors: Vivo Capital, Perceptive Advisors, 5AM Ventures, OrbiMed Advisors, Versant Ventures and RA Capital Management, L.P.

C

Crinetics Pharmaceuticals raised $2.8M on July 13, 2017

Investors: NIDDK, NIH

C

Crinetics Pharmaceuticals raised $40M on November 2, 2015

Investors: 5AM Ventures, Versant Ventures and Vivo Capital

C

Crinetics Pharmaceuticals raised $2.7M on April 27, 2015

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

FAQ